Tue, May 17, 2022
Mon, May 16, 2022
Sun, May 15, 2022
Fri, May 13, 2022
Thu, May 12, 2022
Wed, May 11, 2022

Silvan Tuerkcan Maintained (VOR) at Buy with Decreased Target to $15 on, May 13th, 2022


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-decreased-target-to-15-on-may-13th-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Silvan Tuerkcan of JMP Securities, Maintained "Vor Biopharma Inc." (VOR) at Buy with Decreased Target from $30 to $15 on, May 13th, 2022.

Silvan has made no other calls on VOR in the last 4 months.



There are 2 other peers that have a rating on VOR. Out of the 2 peers that are also analyzing VOR, 1 agrees with Silvan's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Andrea Tan of "Goldman Sachs" Initiated at Hold and Held Target at $6 on, Wednesday, April 27th, 2022


This is the rating of the analyst that currently disagrees with Silvan


  • Carter Gould of "Barclays" Maintained at Buy with Decreased Target to $26 on, Monday, March 21st, 2022

Publication Contributing Sources